Revvity (RVTY) Change in Accured Expenses (2009 - 2026)
Revvity's (RVTY) quarterly Change in Accured Expenses came in at -$74.7 million in Q2 2026, down 114.56% YoY from $513.1 million in Q2 2025, and down 246.14% on a QoQ basis from $51.1 million in Q4 2025.
Revvity (RVTY) Change in Accured Expenses (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Change in Accured Expenses data on file, last reported at -$74.7 million in Q2 2026.
- Quarterly Change in Accured Expenses fell 114.56% year-over-year to -$74.7 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$57.8 million (down 411.26% YoY) and the FY2025 annual result came in at -$17.9 million, up 16.41% from the prior year.
- Change in Accured Expenses declined to -$74.7 million in Q2 2026, from $51.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $92.8 million in Q4 2024 to a low of -$133.7 million in Q3 2023.
- A 5-year average of -$39.2 million and a median of -$44.9 million in 2024 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2024 — Change in Accured Expenses jumped 197.74% — and 2026, when it sank 114.56%.
- Tracing RVTY's Change in Accured Expenses over 5 years: stood at -$105.5 million in 2022, then jumped by 129.56% to $31.2 million in 2023, then jumped by 197.74% to $92.8 million in 2024, then tumbled by 44.95% to $51.1 million in 2025, then plunged by 246.14% to -$74.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$74.7 million (Q2 2026), $51.1 million (Q4 2025), and -$19.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | - |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -249.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -39.33 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 92.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | - |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | - |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 23.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | - |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -24.00 Mn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | -4.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | -4.19 Mn |
| Jul 5, 2026 | -4.19 Mn |
| Apr 5, 2026 | -74.69 Mn |
| Apr 5, 2026 | -74.69 Mn |
| Dec 28, 2025 | 51.11 Mn |
| Dec 28, 2025 | 51.11 Mn |
| Sep 28, 2025 | -19.81 Mn |
| Sep 28, 2025 | -19.81 Mn |
| Jun 29, 2025 | -14.37 Mn |
| Jun 29, 2025 | -14.37 Mn |
| Mar 30, 2025 | -34.81 Mn |
| Mar 30, 2025 | -34.81 Mn |
| Dec 29, 2024 | 92.84 Mn |
| Dec 29, 2024 | 92.84 Mn |
| Sep 29, 2024 | -61.34 Mn |
| Sep 29, 2024 | -61.34 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Jun 30, 2024 | -7.99 Mn |
| Mar 31, 2024 | -44.91 Mn |
| Mar 31, 2024 | -44.91 Mn |